Search Tag: MRSA

Large Decreases in ICU-Acquired Infections - National Infection Campaign

2019 12 Sep

ICUs in the UK have seen an 80% drop in bloodstream infections according to NIHR Guy's and St Thomas' Biomedical Research Centre-funded research. In collaboration with Guy's and St Thomas' clinicians and researchers from ICNARC (Intensive Care National Audit & Research Centre), the study analysed 1 million adult patients from 276 NHS ICUs across the... Read more

Test can identify ICU patients at risk of life-threatening infections

2018 20 Jun

Researchers in the UK say a new test can help identify patients in intensive care units (ICUs) at great risk of developing life-threatening secondary infections, including from antibiotic-resistant bacteria such as MRSA and C. difficile . The test is used to identify the presence of markers on three immune cells that correlate with an increased... Read more

Study: Chlorhexidine Baths Did Not Increase Resistant MRSA

2016 08 Feb

Chlorhexidine baths in the ICU do not cause high levels of resistance in bacteria on patients’ skin, according to a study published in Infection Control & Hospital Epidemiology . The retrospective cohort study of patients admitted to the Barnes-Jewish Hospital ICU in St. Louis, Missouri from 2005 through 2012 included more than 500 randomly selected... Read more

New Antibiotics Group Shows Promise Against Staph, MRSA

2015 15 Sep

Virginia Tech researchers say a new group of antibiotics shows potential in fighting the bacteria Staphylococcus aureus (staph) and the antibiotic-resistant strains commonly known as MRSA. The discovery, published in Medicinal Chemistry Communications , shows that the new antibiotics are unlike contemporary antibiotics because they contain iridium,... Read more

An Innovative Way to Detect Infectious Disease, Superbugs

2015 10 Jul

Researchers at McMaster University have developed a new diagnostic test designed to help clinicians detect infectious diseases such as hepatitis C and deadly superbugs (eg, MRSA and C. difficile) more easily and quickly. They say the new method does not require complicated equipment so tests can be run at room temperature under ordinary conditions.... Read more

Cost of Nosocomial Infections in the ICU

2015 13 Feb

Infections due to multidrug resistant gram negative bacilli (RGNB) in critically ill patients have been reported to be associated with increased morbidity and healthcare costs. A recent study conducted by researchers in Singapore has highlighted the heavy economic burden of RGNB infections to both the patient and hospital. "Nosocomial acquired RGNB... Read more

Study: Protocol Increases Appropriate Antibiotic Use

2015 19 Jan

According to a retrospective study, an antibiotic protocol that determined antibiotic use based on risk for health care-associated infections significantly increased appropriate prescription of antibiotics in a paediatric ICU. The study has been published online in Annals of the American Thoracic Society .   Researchers evaluated patients with an... Read more

New Software Predicts Superbugs' Countermoves to New Drugs

2015 05 Jan

In the fight against drug-resistant bacteria, new drugs are urgently needed, but so are ways to maximise the effective lifespan of these drugs. Researchers at Duke University in the U.S. have developed open-source software that can predict a constantly-evolving infectious bacterium's counter-moves to a new drug before the drug is tested on patients.... Read more

Vancomycin Still Useful For Staph Infections

2014 11 Oct

A new study published in JAMA has determined that vancomycin, an antibiotic that came out more than 50 years ago, remains effective in treating Staphylococcus aureus bloodstream infections. The study's authors said doctors should continue to use the drug even as newer antibiotics can now be bought in the market. Staphylococcus aureus is amongst... Read more

Researchers Uncover Keys to Antibiotic Resistance in MRSA

2013 06 Oct

Methicillin-resistant Staphylococcus aureus (MRSA) is shown in the background (in gray). This figure depicts domains and key ligands of the penicillin binding protein 2a — a key resistance enzyme. The red molecule on the right is ceftaroline, a drug recently approved by the FDA. (Credit: University of Notre Dame) University of Notre Dame researchers... Read more